ARGINASE INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS

The inventive compounds are small molecule therapeutics that are potent inhibitors of arginase 1 and arginase 2 activity. The inventions also provides pharmaceutical compositions and methods for using the inventive compounds for treating or preventing a disease or condition associated with arginase...

Full description

Saved in:
Bibliographic Details
Main Authors BRZEZINSKA, Joanna, GOLEBIOWSKI, Adam A, OLCZAK, Jacek, BLASZCZYK, Roman
Format Patent
LanguageEnglish
French
German
Published 08.11.2017
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The inventive compounds are small molecule therapeutics that are potent inhibitors of arginase 1 and arginase 2 activity. The inventions also provides pharmaceutical compositions and methods for using the inventive compounds for treating or preventing a disease or condition associated with arginase activity.
AbstractList The inventive compounds are small molecule therapeutics that are potent inhibitors of arginase 1 and arginase 2 activity. The inventions also provides pharmaceutical compositions and methods for using the inventive compounds for treating or preventing a disease or condition associated with arginase activity.
Author BLASZCZYK, Roman
GOLEBIOWSKI, Adam A
BRZEZINSKA, Joanna
OLCZAK, Jacek
Author_xml – fullname: BRZEZINSKA, Joanna
– fullname: GOLEBIOWSKI, Adam A
– fullname: OLCZAK, Jacek
– fullname: BLASZCZYK, Roman
BookMark eNrjYmDJy89L5WQwcwxy9_RzDHZV8PTz8HTyDPEPClZw9HNRCPFw9QwCkUGOAa6hIZ7OCo4BAT6ezo4hnv5-wTwMrGmJOcWpvFCam0HBzTXE2UM3tSA_PrW4IDE5NS-1JN41wNjIxMDc3NzR0JgIJQDWsCl4
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate ARGINASE-INHIBITOREN UND DEREN THERAPEUTISCHE ANWENDUNGEN
INHIBITEURS D'ARGINASE ET LEURS APPLICATIONS THÉRAPEUTIQUES
ExternalDocumentID EP3240777A1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP3240777A13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:38:18 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP3240777A13
Notes Application Number: EP20150823405
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171108&DB=EPODOC&CC=EP&NR=3240777A1
ParticipantIDs epo_espacenet_EP3240777A1
PublicationCentury 2000
PublicationDate 20171108
PublicationDateYYYYMMDD 2017-11-08
PublicationDate_xml – month: 11
  year: 2017
  text: 20171108
  day: 08
PublicationDecade 2010
PublicationYear 2017
RelatedCompanies ONCOARENDI THERAPEUTICS S.A
RelatedCompanies_xml – name: ONCOARENDI THERAPEUTICS S.A
Score 3.106581
Snippet The inventive compounds are small molecule therapeutics that are potent inhibitors of arginase 1 and arginase 2 activity. The inventions also provides...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title ARGINASE INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171108&DB=EPODOC&locale=&CC=EP&NR=3240777A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dT4Mw8LJMo77p1Di_woPhjehGB-OBGAZFMBkQxszeFspKshe2bBj_vteGoS_60lza5HK99Hp37X0APFk6fykJIRqeFaIRzkuN5YalDXVGGOPlaiW7KEwjI5iT98Vo0YH1IRdG1gn9ksURUaIKlPda3tfbn0csT8ZW7p_ZGqc2r35me2rjHQ9MEdWuehObJrEXu6rrIqRGqS3qzpmm6aCjdCSsaFFmn35MRFLK9rdG8c_hOEFkVX0BHV714NQ9NF7rwcm0-e9GsBG9_SUYTvoWRs6MKmEUhJMwi9OZ4kSekgU0TMWYOgmdZ6GrOEnSJghfgeLTzA00JGDZbnZJk5ZU_Rq61abiN6CU5aDICzTHUN8QMy_GyPhyNDSYxdDeYaQP_T_R3P6zdgdngmsyuW58D91698kfUMvW7FHy5xuzBHzW
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LTsMwzJoGYtxggBjPHlBvFWzL2u0wob5GA-tDXYd2q5oulXbpJlbE7-NEW-ECl8hKJMux4thO_AB4GPX5U0EI0fCsEI1wXmgs00dar88IY7xYLmUXBT_QvTl5XQwWDVjtc2FkndAvWRwRJSpHea_kfb35ecRyZGzl9pGtcGr9PEnGjrrzjruGiGpXHWvsRqET2qptI6QG8VjUnTMMw0RH6cAQxXmF5fRuiaSUzW-NMjmBwwiRldUpNHjZhpa9b7zWhiN_99-N4E70tmegm_ELDcyZq9DAoxZNwnimmIGjJJ5LYzHGZuTOE2orZhTVCcLnoEzcxPY0JCCtN5u6UU1q_wKa5brkl6AURTfPcjTHUN8QI8uHyPhi0NPZiKG9w0gHOn-iufpn7R5aXuJP0ykN3q7hWHBQJtoNb6BZfXzyW9S4FbuTvPoGsat_ww
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ARGINASE+INHIBITORS+AND+THEIR+THERAPEUTIC+APPLICATIONS&rft.inventor=BRZEZINSKA%2C+Joanna&rft.inventor=GOLEBIOWSKI%2C+Adam+A&rft.inventor=OLCZAK%2C+Jacek&rft.inventor=BLASZCZYK%2C+Roman&rft.date=2017-11-08&rft.externalDBID=A1&rft.externalDocID=EP3240777A1